VOYA INVESTMENT MANAGEMENT LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 116 filers reported holding REVANCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$384,451
-54.1%
33,518
+1.2%
0.00%
-100.0%
Q2 2023$838,394
-14.7%
33,125
+8.5%
0.00%0.0%
Q1 2023$983,114
+74.5%
30,5220.0%0.00%0.0%
Q4 2022$563,436
-24.8%
30,522
+10.0%
0.00%0.0%
Q3 2022$749,169
+99.8%
27,747
+2.2%
0.00%0.0%
Q2 2022$375,000
-30.7%
27,154
-2.1%
0.00%0.0%
Q1 2022$541,000
+19.4%
27,7450.0%0.00%0.0%
Q4 2021$453,000
-40.7%
27,745
+1.2%
0.00%
-50.0%
Q3 2021$764,000
-6.0%
27,4180.0%0.00%0.0%
Q2 2021$813,000
+5.0%
27,418
-1.0%
0.00%0.0%
Q1 2021$774,000
-1.1%
27,689
+0.2%
0.00%0.0%
Q4 2020$783,000
+48.3%
27,629
+31.5%
0.00%
+100.0%
Q3 2020$528,000
+7.8%
21,010
+4.7%
0.00%0.0%
Q2 2020$490,000
+32.1%
20,064
-20.0%
0.00%0.0%
Q1 2020$371,000
+4.8%
25,091
+14.9%
0.00%0.0%
Q4 2019$354,000
+64.7%
21,838
+32.3%
0.00%
Q3 2019$215,000
+4.9%
16,508
+4.6%
0.00%
Q2 2019$205,000
-4.2%
15,775
+15.9%
0.00%
Q1 2019$214,000
-21.9%
13,6060.0%0.00%
-100.0%
Q4 2018$274,000
-11.3%
13,606
+9.4%
0.00%0.0%
Q3 2018$309,000
-9.4%
12,4330.0%0.00%0.0%
Q2 2018$341,000
+6.6%
12,433
+19.6%
0.00%0.0%
Q1 2018$320,000
-14.0%
10,3920.0%0.00%0.0%
Q4 2017$372,000
+30.1%
10,3920.0%0.00%0.0%
Q3 2017$286,000
+4.4%
10,3920.0%0.00%0.0%
Q2 2017$274,000
+35.6%
10,392
+75.5%
0.00%
Q4 2015$202,000
-16.5%
5,920
-21.9%
0.00%
-100.0%
Q2 2015$242,0007,5790.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders